Target intelligence / Profile preview

MicroRNA-2053 (miR-2053)

Target
miR-2053
Molecular classification
MicroRNA, Non-coding RNA, Other
01

Overview

MicroRNA-2053 is a small, non-coding RNA molecule belonging to the microRNA family. It functions as a post-transcriptional regulator of gene expression, primarily acting as a tumor suppressor in various cancers. Overexpression of miR-2053 has been shown to inhibit tumor cell proliferation, migration, and invasion, while inducing apoptosis, particularly in hepatocellular carcinoma and esophageal cancer cell models. These anti-tumor effects are mediated through the downregulation of the PI3K/AKT and Wnt/β-catenin signaling pathways, as well as the targeted repression of genes such as KIF3C. Reduced levels of miR-2053 are associated with cancer progression, suggesting its potential as a therapeutic target or biomarker in oncology[1][2].

Other names
hsa-miR-2053MIR2053hsa-mir-2053
02

Mechanism of action

Tumor suppression via downregulation of PI3K/AKT and Wnt/β-catenin signaling pathways, targeted repression of oncogenes (such as KIF3C)

03

Biological functions

Cell proliferationMigrationInvasionApoptosisCell cycle regulationEpithelial–mesenchymal transition (EMT)Signal transduction (PI3K/AKT pathway, Wnt/β-catenin pathway)
04

Disease associations

Cancer, specifically Hepatocellular carcinoma (HCC)Esophageal cancerlikely other tumor types
05

Safety considerations

none reported; therapeutic challenges may include delivery, off-target effects, and stability, common to microRNA-based interventions
06

Biomarkers

none reported (miR-2053 expression itself could be a potential diagnostic/prognostic cancer biomarker)

Beyond the preview

Go deeper on MicroRNA-2053 (miR-2053).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA-2053 (miR-2053).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call